U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
MEPLAZUMAB
0EL07E29VQ
Investigational
General
Record Details
Names
6
Identifiers
3
Concept Definition
Relationships
2
Active Moiety
1
MEPLAZUMAB
0EL07E29VQ
Investigational
General
Approval Year
Unknown
149,124
Record Details
Substance Class
Concept
Record UNII
0EL07E29VQ
Record Status
Validated (UNII)
Record Version
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
MEPLAZUMAB
Common Name
English
KETANTIN
Preferred Name
English
PMZ201501
Code
English
HUMANIZED IGG2 MONOCLONAL ANTIBODY, CONSISTING OF THE COMPLEMENTARY DETERMINING REGIONS OF ANTI-CD147 MURINE ANTIBODY AND THE HUMAN FRAMEWORK REGION WITH RESTRICTIVE MUTATION.
Common Name
English
Meplazumab [WHO-DD]
Common Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
3
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
NCI_THESAURUS
C172638
PRIMARY
SMS_ID
300000020971
PRIMARY
FDA UNII
0EL07E29VQ
PRIMARY
Showing 1 to 3 of 3 entries
Previous
1
Next
Concept Definition
This is a non-substance concept
Relationships
2
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
B2Q3I03X2Q
BASIGIN-1
TARGET -> INHIBITOR
Amount:
536WV61NML
Plasmodium falciparum
TARGET ORGANISM->INHIBITOR
Comments:
INHIBITOR OF CD
Amount:
Showing 1 to 2 of 2 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
0EL07E29VQ
MEPLAZUMAB
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
This is a non-substance concept